Tag: LifeVantage
New Study: LifeVantage P84 Positively Impacts Gut Health, Peptide Production
November 17, 2025
New in vitro research shows P84 influences key gut peptides – including one by more than 1,000% – supporting cellular pathways tied to regulation, repair, and restoration LifeVantage® Corporation (Nasdaq:LFVN) , a leading health and wellness ...
Read more
LifeVantage Empowers Consultants to “Love Life & Drive” at Momentum Academy 2025
October 31, 2025
Dallas event delivers new products, tools, and business strategies designed to accelerate performance and leadership LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, ...
Read more
LifeVantage Announces Closing of LoveBiome Acquisition
October 5, 2025
Strategic acquisition strengthens leadership position in direct sales and gut and microbiome health market LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, announced ...
Read more
LifeVantage Announces Acquisition of LoveBiome
September 4, 2025
Strategic acquisition expands network of Consultants, and strengthens LifeVantage’s Activation differentiation in the rapidly growing gut health market LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at ...
Read more
LifeVantage Announces Expanded Clinical Study for MindBody GLP-1 System™
July 29, 2025
LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, announced new results from its second human clinical study on the MindBody GLP-1 System™, revealing ...
Read more
LifeVantage Hosts Activate 2025, Unveils New Quarterly Business Campaign, Incentives to Drive Global Growth
July 17, 2025
LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, held its global Activate 2025 virtual event on Saturday, July 12. The event, supported by ...
Read more
LifeVantage Revenue Q1 2025 Up 21.1% To $58.4 Million
May 7, 2025
LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2025. Third ...
Read more
LifeVantage Welcomes Thousands From Around the World at Global Convention
April 30, 2025
Attended By Over 2,000 Independent Consultants, LifeVantage Global Convention Hosted in Salt Lake City, Utah, Empowers Consultants to ‘Go Further’ With Exclusive Trainings, Product Announcements, and New Incentives to Drive Growth. LifeVantage Corporation® (Nasdaq: LFVN), a leading ...
Read more
LifeVantage Launches MB System™ in International Markets
March 23, 2025
LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, is extending its groundbreaking MindBody GLP-1 System™ to international markets. This expansion comes after a 49% ...
Read more
LifeVantage Expands To The Philippines, Taiwan, Hong Kong And Singapore
March 5, 2025
LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the successful launch of the Evolve Compensation Plan and other LV360 initiatives into the ...
Read more
Renee Parker Featured Recommended Distributor For LifeVantage
February 11, 2025
A beacon of success in the network marketing industry, Renee Parker has admirably secured her position as a Featured Recommended Distributor. She stands as an inspiration through her association with LifeVantage, a world-renowned network marketing company. ...
Read more
LifeVantage Q4 2024 Revenue Up 31.3% To $67.8 Million
February 7, 2025
LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its second fiscal quarter ended December 31, 2024. Second Quarter Fiscal 2025 Summary*: Revenue of $67.8 ...
Read more